HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natural killer T cells and autoimmune disease.

Abstract
Natural killer T (NKT) cells are an unusual subset of innate immune cells that express a surface receptor generated by somatic DNA rearrangement, a hallmark of cells of the adaptive immune system. NKT cells express a highly restricted repertoire of T cell receptors that recognize glycolipid antigens bound with the antigen-presenting molecule CD1d. A hallmark of NKT cells is their capacity to produce copious amounts of immunomodulatory cytokines upon antigenic stimulation, which endows these cells with potent immunoregulatory properties. Consequently, NKT cells have been implicated in regulating a wide variety of immune responses, including immune responses against autoantigens. In patients and mice with a variety of autoimmune diseases, numbers and functions of NKT cells are disturbed, but the relevance of these findings to the etiology of autoimmunity remains to be fully established. Nevertheless, in some mouse models of autoimmunity, NKT cell-deficiency exacerbates disease, suggesting that NKT cells play a role in suppressing autoimmunity. Conversely, specific activation of NKT cells with glycolipid antigens generally protects mice against the development of autoimmunity. Most of these studies have employed the potent sponge-derived NKT cell antigen alpha-galactosylceramide (alpha-GalCer). However, alpha-GalCer treatment in mice was associated with detrimental side effects and treatment efficacy was influenced by a variety of parameters, resulting sometimes in disease exacerbation rather than protection. Recent efforts have focused on developing NKT cell agonists with superior treatment efficacy than alpha-GalCer. Collectively, these studies have identified NKT cells as attractive targets for treatment of human autoimmune diseases.
AuthorsLan Wu, Luc Van Kaer
JournalCurrent molecular medicine (Curr Mol Med) Vol. 9 Issue 1 Pg. 4-14 (Feb 2009) ISSN: 1566-5240 [Print] Netherlands
PMID19199937 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Topics
  • Animals
  • Arthritis, Rheumatoid (immunology)
  • Autoimmune Diseases (immunology, therapy)
  • Autoimmunity (immunology)
  • Diabetes Mellitus, Type 1 (immunology)
  • Disease Models, Animal
  • Humans
  • Immunity, Innate
  • Immunotherapy
  • Liver Cirrhosis, Biliary (immunology)
  • Lupus Erythematosus, Systemic (immunology)
  • Mice
  • Multiple Sclerosis (immunology)
  • Myasthenia Gravis (immunology)
  • Natural Killer T-Cells (physiology)
  • Self Tolerance (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: